Transseptal Needle Versus Radiofrequency Energy for Left Atrial Access (TRAVERSE-LA)
Primary Purpose
Heart Diseases
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Radiofrequency energy needle
Mechanical Needle
Sponsored by

About this trial
This is an interventional treatment trial for Heart Diseases focused on measuring Transseptal Puncture, Radiofrequency Energy, Left Atrium Access, Left Atrial Catheterization, Ablation, Transseptal Catheterization, Electrocautery, Catheter Ablation, Atrial Fibrillation
Eligibility Criteria
Inclusion Criteria:
- Patients undergoing radiofrequency ablation within the left atrium through a transseptal approach
- Patients greater than 18 years of age
Exclusion Criteria:
- Patients unable to grant informed, written consent
Sites / Locations
- University of California, San Francisco
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Radiofrequency energy needle
Mechanical needle
Arm Description
Radiofrequency energy needle for transseptal access
Mechanical (Brockenbrough) needle for transseptal access
Outcomes
Primary Outcome Measures
Transseptal Access Procedure Time
Total amount of procedure time, from the beginning of the transseptal procedure until left atrium (LA) access is obtained in each patient. Participants for whom puncture failed crossed over to the other Intervention. Analysis performed on an intention-to-treat basis.
Secondary Outcome Measures
Number of Participants With Adverse Events as a Measure of Safety
Performance of the Assigned Needle Type
Failure to achieve transseptal access with the assigned needle type resulted in crossover because of an inability to puncture the interatrial septem despite forward pressure and tenting, leading to concern that further effort might lead to perforation of the free (lateral) LA wall.
Plastic Dilator Shavings
In ex vivo pre-procedural testing, the assigned transseptal needle was advanced through the plastic dilator and sheath, and the presence of grossly visible plastic shavings after introduction of the needle through the dilator and long sheath was recorded.
Full Information
NCT ID
NCT01209260
First Posted
September 9, 2010
Last Updated
January 28, 2014
Sponsor
University of California, San Francisco
Collaborators
Baylis Medical Company
1. Study Identification
Unique Protocol Identification Number
NCT01209260
Brief Title
Transseptal Needle Versus Radiofrequency Energy for Left Atrial Access
Acronym
TRAVERSE-LA
Official Title
Transseptal Needle Versus Radiofrequency Energy for Left Atrial Access (TRAVERSE-LA): A Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
January 2014
Overall Recruitment Status
Completed
Study Start Date
November 2010 (undefined)
Primary Completion Date
November 2012 (Actual)
Study Completion Date
November 2012 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of California, San Francisco
Collaborators
Baylis Medical Company
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a randomized controlled trial examining whether a mechanical needle versus a needle that uses radiofrequency energy is better at puncturing through a thin wall in the heart (called "transseptal puncture") as measured by procedure time, during an electrical procedure/study of the heart .
Detailed Description
Transseptal puncture is a commonly performed procedure allowing access to the left atrium for catheter ablation. Historically, a conventional Brockenbrough needle has been used for this procedure to mechanically puncture the fossa ovalis, which has been well described in the literature.1, 2 Although generally safe, serious complications such as perforation of the atrial wall or aorta can occur.3, 4
Previous studies have evaluated the feasibility and safety of radiofrequency (RF) energy applied to a conventional needle as a technique to access the left atrium, particularly in patients with a repeat procedure, fibrotic septum or aneurysmal septum.5, 6 As a result of this earlier work, a special proprietary device has been designed. The NRG RF needle (Baylis Medical Inc., Montreal, Canada), uses radiofrequency energy emitted from the needle tip to aid in transseptal access. Despite limited literature to support its superiority and safety7-9compared to the conventional approach, the new device has become adopted in some electrophysiology procedures involving a transseptal puncture.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Diseases
Keywords
Transseptal Puncture, Radiofrequency Energy, Left Atrium Access, Left Atrial Catheterization, Ablation, Transseptal Catheterization, Electrocautery, Catheter Ablation, Atrial Fibrillation
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
72 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Radiofrequency energy needle
Arm Type
Experimental
Arm Description
Radiofrequency energy needle for transseptal access
Arm Title
Mechanical needle
Arm Type
Active Comparator
Arm Description
Mechanical (Brockenbrough) needle for transseptal access
Intervention Type
Device
Intervention Name(s)
Radiofrequency energy needle
Other Intervention Name(s)
Baylis Medical Inc. transseptal needle, NRG RF transseptal needle
Intervention Description
Radiofrequency energy needle for transseptal access
Intervention Type
Device
Intervention Name(s)
Mechanical Needle
Other Intervention Name(s)
Brockenbrough Needle
Intervention Description
Mechanical needle for transseptal access
Primary Outcome Measure Information:
Title
Transseptal Access Procedure Time
Description
Total amount of procedure time, from the beginning of the transseptal procedure until left atrium (LA) access is obtained in each patient. Participants for whom puncture failed crossed over to the other Intervention. Analysis performed on an intention-to-treat basis.
Time Frame
Day of procedure
Secondary Outcome Measure Information:
Title
Number of Participants With Adverse Events as a Measure of Safety
Time Frame
During or immediately after procedure, up to 1 day after procedure. On average, up to 1 day after the procedure.
Title
Performance of the Assigned Needle Type
Description
Failure to achieve transseptal access with the assigned needle type resulted in crossover because of an inability to puncture the interatrial septem despite forward pressure and tenting, leading to concern that further effort might lead to perforation of the free (lateral) LA wall.
Time Frame
at time of procedure
Title
Plastic Dilator Shavings
Description
In ex vivo pre-procedural testing, the assigned transseptal needle was advanced through the plastic dilator and sheath, and the presence of grossly visible plastic shavings after introduction of the needle through the dilator and long sheath was recorded.
Time Frame
immediately prior to procedure
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients undergoing radiofrequency ablation within the left atrium through a transseptal approach
Patients greater than 18 years of age
Exclusion Criteria:
Patients unable to grant informed, written consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Gregory Marcus, MD
Organizational Affiliation
University of California, San Francisco
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jonathan Hsu, MD
Organizational Affiliation
University of California, San Francisco
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of California, San Francisco
City
San Francisco
State/Province
California
ZIP/Postal Code
94143
Country
United States
12. IPD Sharing Statement
Citations:
PubMed Identifier
13649591
Citation
ROSS J Jr, BRAUNWALD E, MORROW AG. Transseptal left atrial puncture; new technique for the measurement of left atrial pressure in man. Am J Cardiol. 1959 May;3(5):653-5. doi: 10.1016/0002-9149(59)90347-9. No abstract available.
Results Reference
background
PubMed Identifier
3943231
Citation
B-Lundqvist C, Olsson SB, Varnauskas E. Transseptal left heart catheterization: a review of 278 studies. Clin Cardiol. 1986 Jan;9(1):21-6. doi: 10.1002/clc.4960090105.
Results Reference
background
PubMed Identifier
7987913
Citation
Roelke M, Smith AJ, Palacios IF. The technique and safety of transseptal left heart catheterization: the Massachusetts General Hospital experience with 1,279 procedures. Cathet Cardiovasc Diagn. 1994 Aug;32(4):332-9. doi: 10.1002/ccd.1810320409.
Results Reference
background
PubMed Identifier
16516090
Citation
De Ponti R, Cappato R, Curnis A, Della Bella P, Padeletti L, Raviele A, Santini M, Salerno-Uriarte JA. Trans-septal catheterization in the electrophysiology laboratory: data from a multicenter survey spanning 12 years. J Am Coll Cardiol. 2006 Mar 7;47(5):1037-42. doi: 10.1016/j.jacc.2005.10.046. Epub 2006 Feb 9.
Results Reference
background
PubMed Identifier
17997362
Citation
Bidart C, Vaseghi M, Cesario DA, Mahajan A, Fujimura O, Boyle NG, Shivkumar K. Radiofrequency current delivery via transseptal needle to facilitate septal puncture. Heart Rhythm. 2007 Dec;4(12):1573-6. doi: 10.1016/j.hrthm.2007.07.008. Epub 2007 Jul 14. No abstract available.
Results Reference
background
PubMed Identifier
11553955
Citation
Justino H, Benson LN, Nykanen DG. Transcatheter creation of an atrial septal defect using radiofrequency perforation. Catheter Cardiovasc Interv. 2001 Sep;54(1):83-7. doi: 10.1002/ccd.1244.
Results Reference
background
PubMed Identifier
19925604
Citation
Smelley MP, Shah DP, Weisberg I, Kim SS, Lin AC, Beshai JF, Burke MC, Knight BP. Initial experience using a radiofrequency powered transseptal needle. J Cardiovasc Electrophysiol. 2010 Apr;21(4):423-7. doi: 10.1111/j.1540-8167.2009.01656.x. Epub 2009 Nov 17.
Results Reference
background
PubMed Identifier
15736263
Citation
Sakata Y, Feldman T. Transcatheter creation of atrial septal perforation using a radiofrequency transseptal system: novel approach as an alternative to transseptal needle puncture. Catheter Cardiovasc Interv. 2005 Mar;64(3):327-32. doi: 10.1002/ccd.20284.
Results Reference
background
PubMed Identifier
20506170
Citation
Crystal MA, Mirza MA, Benson LN. A radiofrequency transseptal needle: initial animal studies. Catheter Cardiovasc Interv. 2010 Nov 1;76(5):769-73. doi: 10.1002/ccd.22600.
Results Reference
background
PubMed Identifier
24045120
Citation
Hsu JC, Badhwar N, Gerstenfeld EP, Lee RJ, Mandyam MC, Dewland TA, Imburgia KE, Hoffmayer KS, Vedantham V, Lee BK, Tseng ZH, Scheinman MM, Olgin JE, Marcus GM. Randomized trial of conventional transseptal needle versus radiofrequency energy needle puncture for left atrial access (the TRAVERSE-LA study). J Am Heart Assoc. 2013 Sep 17;2(5):e000428. doi: 10.1161/JAHA.113.000428.
Results Reference
derived
Learn more about this trial
Transseptal Needle Versus Radiofrequency Energy for Left Atrial Access
We'll reach out to this number within 24 hrs